JC
PFE icon

Jacobs & Co’s Pfizer PFE Stock Holding History

Jacobs & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99M Sell
82,804
-41,625
-33% -$1.09M 0.17% 80
2026
Q1 		$3.49M Sell
124,429
-31,071
-20% -$827K 0.34% 75
2025
Q4 		$3.87M Sell
155,500
-28,066
-15% -$708K 0.37% 71
2025
Q3 		$4.68M Sell
183,566
-9,015
-5% -$223K 0.45% 69
2025
Q2 		$4.67M Sell
192,581
-36,261
-16% -$846K 0.46% 69
2025
Q1 		$5.8M Sell
228,842
-9,180
-4% -$240K 0.62% 66
2024
Q4 		$6.31M Sell
238,022
-50,340
-17% -$1.37M 0.64% 62
2024
Q3 		$8.35M Sell
288,362
-33,098
-10% -$966K 0.83% 51
2024
Q2 		$8.99M Sell
321,460
-15,823
-5% -$436K 0.94% 46
2024
Q1 		$9.36M Buy
337,283
+7,260
+2% +$201K 0.99% 45
2023
Q4 		$9.5M Buy
330,023
+5,190
+2% +$157K 1.08% 39
2023
Q3 		$10.8M Buy
324,833
+7,173
+2% +$254K 1.34% 29
2023
Q2 		$11.7M Sell
317,660
-6,794
-2% -$264K 1.39% 26
2023
Q1 		$13.2M Buy
324,454
+3,875
+1% +$167K 1.63% 14
2022
Q4 		$16.4M Buy
320,579
+124
+0% +$5.95K 2.14% 4
2022
Q3 		$14M Buy
320,455
+8,352
+3% +$406K 2.02% 6
2022
Q2 		$16.4M Sell
312,103
-1,343
-0.4% -$68.4K 2.19% 5
2022
Q1 		$16.2M Sell
313,446
-4,357
-1% -$226K 1.8% 13
2021
Q4 		$18.8M Buy
317,803
+1,127
+0.4% +$55.8K 1.95% 12
2021
Q3 		$13.6M Buy
316,676
+8,824
+3% +$391K 1.57% 20
2021
Q2 		$12.1M Buy
307,852
+6,434
+2% +$250K 1.39% 25
2021
Q1 		$10.9M Buy
301,418
+19,970
+7% +$709K 1.33% 27
2020
Q4 		$10.4M Sell
281,448
-6,552
-2% -$240K 1.35% 27
2020
Q3 		$10M Buy
288,000
+73,344
+34% +$2.57M 1.45% 22
2020
Q2 		$6.66M Buy
214,656
+27,469
+15% +$933K 1.08% 35
2020
Q1 		$5.8M Sell
187,187
-5,117
-3% -$174K 1.12% 35
2019
Q4 		$7.15M Buy
192,304
+8,071
+4% +$287K 1.09% 35
2019
Q3 		$6.28M Sell
184,233
-4,087
-2% -$149K 1.02% 36
2019
Q2 		$7.74M Sell
188,320
-622
-0.3% -$24.7K 1.25% 31
2019
Q1 		$7.61M Sell
188,942
-3,646
-2% -$146K 1.3% 30
2018
Q4 		$7.98M Sell
192,588
-5,319
-3% -$221K 1.57% 23
2018
Q3 		$8.27M Sell
197,907
-8,840
-4% -$340K 1.4% 25
2018
Q2 		$7.12M Sell
206,747
-2,682
-1% -$91.7K 1.29% 31
2018
Q1 		$7.05M Sell
209,429
-822
-0.4% -$28.3K 1.3% 33
2017
Q4 		$7.22M Sell
210,251
-1,509
-0.7% -$51.5K 1.31% 35
2017
Q3 		$7.17M Sell
211,760
-1,742
-0.8% -$56K 1.35% 35
2017
Q2 		$6.8M Sell
213,502
-2,228
-1% -$70.3K 1.34% 35
2017
Q1 		$7M Sell
215,730
-164
-0.1% -$5.17K 1.44% 28
2016
Q4 		$6.65M Buy
215,894
+2,169
+1% +$66.2K 1.44% 27
2016
Q3 		$6.87M Buy
213,725
+2,132
+1% +$71.3K 1.53% 24
2016
Q2 		$7.07M Sell
211,593
-3,984
-2% -$127K 1.66% 21
2016
Q1 		$6.06M Sell
215,577
-6,901
-3% -$197K 1.46% 26
2015
Q4 		$6.54M Sell
222,478
-71
-0% -$2.23K 1.69% 16
2015
Q3 		$6.63M Buy
222,549
+4,778
+2% +$153K 1.76% 12
2015
Q2 		$6.93M Buy
217,771
+2,311
+1% +$75.3K 1.73% 13
2015
Q1 		$7.11M Buy
215,460
+7,765
+4% +$247K 1.8% 11
2014
Q4 		$6.14M Buy
207,695
+6,100
+3% +$175K 1.62% 20
2014
Q3 		$5.66M Buy
201,595
+9,673
+5% +$271K 1.6% 16
2014
Q2 		$5.4M Buy
191,922
+5,904
+3% +$168K 1.57% 20
2014
Q1 		$5.67M Sell
186,018
-1,813
-1% -$54.1K 1.76% 16
2013
Q4 		$5.46M Sell
187,831
-2,008
-1% -$58.4K 1.75% 15
2013
Q3 		$5.17M Sell
189,839
-5,928
-3% -$161K 1.8% 12
2013
Q2 		$5.2M Buy
+195,767
New +$5.41M 1.89% 11

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Jacobs & Co's PFE Position: Q2 2026 in Review

Jacobs & Co reduced its Pfizer (PFE) stake by 33% in Q2 2026, selling an estimated $1.09M and leaving 82,804 shares worth $1.99M. The position accounts for 0.17% of the portfolio, ranked #80.

Jacobs & Co first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.8M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Jacobs & Co held 82,804 shares of Pfizer worth $1.99M as of Q2 2026.
  • Jacobs & Co sold 41,625 Pfizer shares in Q2 2026, an estimated $1.09M.
  • Pfizer made up 0.17% of Jacobs & Co's portfolio in Q2 2026, its #80 holding.
  • Jacobs & Co first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Jacobs & Co's Pfizer position peaked at $18.8M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Jacobs & Co's 13F filing for Q2 2026, filed 9 Jul 2026.